Medical Technologies

Medical devices, digital health, medical artificial intelligence, surgical robots, and diagnostic technologies.

9 Articles

VIDRAFT Launches an Open Challenge to Evaluate AI-Designed Malaria Drug Molecules

VIDRAFT has announced the opening of the first season of the Open Discovery Challenge, a public leaderboard that evaluates AI-designed malaria drug candidates using metrics including intracellular activity, target binding, selectivity, toxicity, and manufacturability. The malaria season runs until September 30, 2026, and the leader receives a $1,000 prize.

2026-08-15

Medical Technologies

AMS shareholders approve sale of the company to H.B. Fuller for £715 million

H.B. Fuller received approval from Advanced Medical Solutions Group shareholders for the acquisition deal, which is expected to be completed before the end of 2026. The deal will expand H.B. Fuller’s presence in surgical biomaterials, adhesives and medical mechanical closures.

2026-08-14

Medical Technologies

Healthcare AI Alliance Forms Working Group to Address Risks of Advanced AI Models

The Coalition for Health AI formed a working group comprising approximately 100 leaders from healthcare systems, insurance companies, and the technology sector, with the goal of developing cybersecurity guidance and tools related to advanced AI models before the end of 2026. The group will focus on helping healthcare organizations defend against attacks and use these models safely.

2026-08-14

Medical Technologies

Senseonics Completes Transfer of Eversense 365 Sales to Internal Management and Plans Fully Implantable Sensor

Senseonics has completed the transfer of marketing and sales operations for the Eversense 365 continuous glucose monitor from Ascensia Diabetes Care to its internal teams in the United States and Europe, coinciding with record revenue of $14.5 million in the second quarter. The company is developing a fully implantable version of the sensor capable of communicating directly with a phone for one year.

2026-08-13

Medical Technologies

Google unveils Pixel Watch 5 with Gemini assistant and advanced health tracking

Google announced the Pixel Watch 5, combining a proactive Gemini assistant with improvements to GPS tracking and Health Guardian features for monitoring health indicators and monthly trends. Preorders begin on August 12, and the device will go on sale on August 20 at a starting price of $399.

2026-08-12

Medical Technologies

Orthopedic Companies Do Not Expect Implant Prices to Decline Despite Medicare Changes

Stryker and Zimmer Biomet believe the new Medicare model for joint replacement surgeries will not put much pressure on implant prices, while an analyst warns that medical device companies may have to demonstrate the technological impact of their products in reducing readmissions and emergency visits.

2026-08-11

Medical Technologies

Medical Device Companies Support MDUFA VI Agreement, While Patients Call for Stronger Post-Market Safety

The latest agreement to fund medical device fees in the United States enjoys broad industry support, but patient groups are calling for expanded use of real-world evidence to monitor devices after they reach the market. The agreement includes higher fees for foreign companies, greater transparency regarding staffing at the medical device division, and the conversion of the TAP program into a permanent program.

2026-08-10

Medical Technologies

When Is Building Software Better Than Buying It? NYU Langone and Dana-Farber’s Experience Supporting Cancer Treatment Decisions

NYU Langone Health and Dana-Farber Cancer Institute developed the Solavia Decision Suite to help oncologists connect patient data with research, guidelines, and treatments within the electronic health record. After testing it internally, the platform became commercially available to other health systems in an experience that highlights the criteria for choosing between building and buying software.

2026-08-10

Medical Technologies

Six Trends That Reshaped the Landscape of Medical Innovation in 2025

IEEE Spectrum’s review of the most prominent biomedical stories of 2025 highlights a mix of artificial intelligence applications and older technologies repurposed for new uses, from brain implants and graphene tattoos to Wi-Fi heart monitoring and robotic surgery. These examples reveal promising opportunities, but they remain at varying research or experimental stages and face challenges related to accuracy, safety, and privacy.

2025-12-21